Search

Your search keyword '"Conjugated estrogens -- Reports -- Forecasts and trends"' showing total 13 results
Start Over Descriptor "Conjugated estrogens -- Reports -- Forecasts and trends" Publication Year Range Last 50 years
13 results on '"Conjugated estrogens -- Reports -- Forecasts and trends"'

1. Coherent Market Insight: Global Menopause Treatment Market Set to Hit $24.33 Billion by 2031

Subjects
Conjugated estrogens -- Reports -- Forecasts and trends, Dietary supplements -- Reports -- Forecasts and trends, Menopause -- Drug therapy, Medicine, Botanic -- Reports -- Forecasts and trends, Medicine, Herbal -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Arts and entertainment industries
Abstract

The Global Menopause Treatment Market size is projected to grow from USD 15.21 billion in 2023 to USD 24.33 billion by 2031, at a CAGR of 5.9 percent,as per the [...]

Published
2024

2. Coherent Market Insights: Global Menopause Treatment Market Set to reach $24.33 Billion by 2031

Subjects
Conjugated estrogens -- Reports -- Forecasts and trends, Dietary supplements -- Reports -- Forecasts and trends, Menopause -- Drug therapy, Medicine, Botanic -- Reports -- Forecasts and trends, Medicine, Herbal -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Arts and entertainment industries
Abstract

The Global Menopause Treatment Marketsize is projected to grow from USD 15.21 billion in 2023 to USD 24.33 billion by 2031, at a CAGR of 5.9 percent,as per the recent [...]

Published
2024

3. Menopause Market Size in the 7MM was ~USD 10,970 million in 2023, estimated DelveInsight

Subjects
Astellas Pharma Inc. -- Forecasts and trends, Business -- Research, Denosumab -- Forecasts and trends -- Reports, Menopause -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Epidemiology -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-November 19, 2024-: Menopause Market Size in the 7MM was ~USD 10,970 million in 2023, estimated DelveInsight (C)1994-2024 M2 COMMUNICATIONS RDATE:18112024 The Menopause Market is driven by the rising [...]

Published
2024

4. Coherent Market Insight: Global Menopause Treatment Market Set to Hit $24.33 Billion by 2031

Subjects
Conjugated estrogens -- Reports -- Forecasts and trends, Dietary supplements -- Reports -- Forecasts and trends, Menopause -- Drug therapy, Medicine, Botanic -- Reports -- Forecasts and trends, Medicine, Herbal -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Telecommunications industry
Abstract

The Global Menopause Treatment Market size is projected to grow from USD 15.21 billion in 2023 to USD 24.33 billion by 2031, at a CAGR of 5.9 percent,as per the [...]

Published
2024

5. Coherent Market Insights: Global Menopause Treatment Market Set to reach $24.33 Billion by 2031

Subjects
Conjugated estrogens -- Reports -- Forecasts and trends, Dietary supplements -- Reports -- Forecasts and trends, Menopause -- Drug therapy, Medicine, Botanic -- Reports -- Forecasts and trends, Medicine, Herbal -- Reports -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international, Telecommunications industry
Abstract

The Global Menopause Treatment Marketsize is projected to grow from USD 15.21 billion in 2023 to USD 24.33 billion by 2031, at a CAGR of 5.9 percent,as per the recent [...]

Published
2024

6. United States Sex Reassignment Hormone Therapy (Male-To-Female, Female-To-Male) Market Size, Share & Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Subjects
Pfizer Inc. -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Sex change -- Forecasts and trends -- Reports, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

DUBLIN: RESEARCH AND MARKETS has issued the following news release: The 'U.S. Sex Reassignment Hormone Therapy Market Size, Share & Trends Analysis Report By Gender Transition (Male-To-Female, Female-To-Male), By Type [...]

Published
2023

7. United States Sex Reassignment Hormone Therapy (Male-To-Female, Female-To-Male) Market Size, Share & Trends Analysis Report 2023-2030

Subjects
Pfizer Inc. -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Sex change -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-December 11, 2023-: United States Sex Reassignment Hormone Therapy (Male-To-Female, Female-To-Male) Market Size, Share & Trends Analysis Report 2023-2030 (C)1994-2023 M2 COMMUNICATIONS RDATE:11122023 The 'U.S. Sex Reassignment Hormone Therapy [...]

Published
2023

8. Osteoporosis: Global Drug Forecast & Market Analysis to 2027

Subjects
Denosumab -- Reports -- Forecasts and trends, Osteoporosis -- Reports -- Forecasts and trends, Bazedoxifene -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Abaloparatide -- Reports -- Forecasts and trends, Generic drugs -- Reports -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Evenity (Medication) -- Reports
Abstract

DUBLIN: Research and Markets has issued the following press release: The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been added to ResearchAndMarkets.com's offering. Despite being a [...]

Published
2019

9. Global Osteoporosis Market & Drug Outlook 2017-2027: Current Market Leader Prolia Will Make Way for New Anabolic Therapies

Subjects
Denosumab -- Reports -- Forecasts and trends, Osteoporosis -- Reports -- Forecasts and trends, Bazedoxifene -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Abaloparatide -- Reports -- Forecasts and trends, Generic drugs -- Reports -- Forecasts and trends, Competition (Economics), Market trend/market analysis, Banking, finance and accounting industries, Business, Evenity (Medication) -- Reports, Prolia (Medication) -- Reports
Abstract

Dublin, July 05, Jul 05, 2019 (GLOBE NEWSWIRE via COMTEX) -- The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been added to ResearchAndMarkets.com's offering. Despite being [...]

Published
2019

10. Osteoporosis: Global Drug Forecast & Market Analysis to 2027 - ResearchAndMarkets.com

Subjects
Denosumab -- Reports -- Forecasts and trends, Osteoporosis -- Reports -- Forecasts and trends, Bazedoxifene -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Abaloparatide -- Reports -- Forecasts and trends, Generic drugs -- Reports -- Forecasts and trends, Competition (Economics), Market trend/market analysis, Business, Business, international, Evenity (Medication) -- Reports
Abstract

DUBLIN -- The 'Osteoporosis: Global Drug Forecast and Market Analysis to 2027' report has been added to ResearchAndMarkets.com's offering. Despite being a market currently monopolized by generics, osteoporosis is expected [...]

Published
2019

11. Hormone Replacement Therapy Market Forecasts to 2024: Anticipating a CAGR of Approx 6.5%

Subjects
Bazedoxifene -- Reports -- Forecasts and trends, Hormone replacement therapy -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Postmenopausal women -- Reports -- Forecasts and trends, Menopause -- Reports -- Forecasts and trends, Novels, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Dublin: Research and Markets has issued the following press release: The 'Hormone Replacement Therapy Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's offering. [...]

Published
2019

12. Analysis on the Global Hormone Replacement Therapy Market 2019-2024 - Abbott, Bayer, Merck, Novartis, and Pfizer Hold the Largest Shares - ResearchAndMarkets.com

Subjects
Bazedoxifene -- Reports -- Forecasts and trends, Hormone replacement therapy -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Postmenopausal women -- Reports -- Forecasts and trends, Menopause -- Reports -- Forecasts and trends, Stocks, Novels, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Hormone Replacement Therapy Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's offering. The market for hormone replacement therapy is expected [...]

Published
2019

13. Hormone Replacement Therapy Market Forecasts to 2024: Anticipating a CAGR of Approx 6.5%

Subjects
Bazedoxifene -- Reports -- Forecasts and trends, Hormone replacement therapy -- Reports -- Forecasts and trends, Conjugated estrogens -- Reports -- Forecasts and trends, Postmenopausal women -- Reports -- Forecasts and trends, Menopause -- Reports -- Forecasts and trends, Novels, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, June 18, Jun 18, 2019 (GLOBE NEWSWIRE via COMTEX) -- The 'Hormone Replacement Therapy Market - Growth, Trends, and Forecast (2019 - 2024)' report has been added to ResearchAndMarkets.com's [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results